Correspondence

HPV vaccine: Can we afford to hesitate?

Karin Louise Richter, Greta Dreyer, Barend Gerhardus Lindeque, Marthinus Hendrik Botha

Abstract


-

Authors' affiliations

Karin Louise Richter, Department of Medical Virology, Faculty of Health Sciences, University of Pretoria and National Health Laboratory Services, Pretoria, South Africa

Greta Dreyer, Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Pretoria, South Africa

Barend Gerhardus Lindeque, Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Pretoria, South Africa

Marthinus Hendrik Botha, Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa

Full Text

PDF (537KB)

Keywords

HPV vaccine; Cervical cancer

Cite this article

South African Medical Journal 2014;104(8):522-523. DOI:10.7196/SAMJ.8449

Article History

Date submitted: 2014-05-13
Date published: 2014-06-19

Article Views

Abstract views: 1194
Full text views: 695

Comments on this article

*Read our policy for posting comments here